$VODG(.04)...pretty interesting/unnoticed disclosu
Post# of 106952
(Total Views: 588)
Posted On: 05/03/2018 6:33:14 PM
$VODG(.04)...pretty interesting/unnoticed disclosure in today's press release......
There is suspension/revocation risk involved with VODG because of its filing status. But that negative aspect aside, it might be worth putting VODG on a watchlist since things seem to be getting quite a bit more interesting (from an operational/business standpoint) at the company in the last year or so. Revenues should continue to show healthy improvement as the NutraVivo line of products are introduced and the stem cell products continue to gain traction in the market.
Today's press release contained some information that appears to have gone largely unnoticed by the market. VODG generally has been relatively reluctant over the years to provide much specific information on where (and in what manner) many of its products are being used. So today's disclosure that VODG's Allogenic Stem Cells are being used as an alternative treatment at a New Zealand medical facility is quite interesting.......
From the April 17, 2018 article......
https://www.stuff.co.nz/national/103061387/ex...-cerebella
Also, it is interesting to note (from reading the patient's husband's social media posting) that two additional patients started their treatments using VODG stem cells in March of 2018.....
https://givealittle.co.nz/cause/jackies-msa-c...nt/updates
There is suspension/revocation risk involved with VODG because of its filing status. But that negative aspect aside, it might be worth putting VODG on a watchlist since things seem to be getting quite a bit more interesting (from an operational/business standpoint) at the company in the last year or so. Revenues should continue to show healthy improvement as the NutraVivo line of products are introduced and the stem cell products continue to gain traction in the market.
Today's press release contained some information that appears to have gone largely unnoticed by the market. VODG generally has been relatively reluctant over the years to provide much specific information on where (and in what manner) many of its products are being used. So today's disclosure that VODG's Allogenic Stem Cells are being used as an alternative treatment at a New Zealand medical facility is quite interesting.......
Quote:
Tiana Tonrey, C.O.O. of Vitro BioPharma, said, "We are pleased with our commercialization progress with the completion of our clean room in 2017 and the addition of qualified technical support we have the capacity and utilization to meet the growing demand for our Allogenic Stem Cells that we are now actively shipping to three corners of the world. Our world class Allogenic Stem Cells are helping patients around the world. See a recent testimonial at: https://www.stuff.co.nz/national/103061387/ex...lla."
From the April 17, 2018 article......
Quote:
But an experimental treatment developed in the US and administered in New Zealand, is providing hope. In his quest for answers, Bill discovered A PhD researcher, who was working in a FDA approved research lab in the US. He was conducting research using stem cells help people with TBI (traumatic brain injuries). They have been able to regenerate damaged brain cells.
https://www.stuff.co.nz/national/103061387/ex...-cerebella
Also, it is interesting to note (from reading the patient's husband's social media posting) that two additional patients started their treatments using VODG stem cells in March of 2018.....
Quote:
The 2nd of March is a RED letter day because two other people had their first stem cells treatment. We wish them the same success.
https://givealittle.co.nz/cause/jackies-msa-c...nt/updates
(0)
(0)